Insights

Global Diagnostic Leader Diasorin's extensive international presence across five continents with 35 companies and 10 manufacturing facilities positions it as a prime target for expanding its reagent kit sales and diagnostic services in emerging markets and regions with growing healthcare investments.

Innovative R&D Focus With over 400 research professionals and continuous investment in research centers, Diasorin is likely to seek cutting-edge technologies and collaborations, creating opportunities for partners offering novel diagnostic assays, life science reagents, or digital health solutions.

Strong Financial Growth The company's recent uptick in revenue and robust free cash flow of 191 million EUR suggest they are investing in expansion and acquisitions, making this an ideal time to propose tailored solutions in diagnostics equipment, automation, or complementary healthcare products.

Focus on Specialty Tests Diasorin's broad range of specialty in vitro diagnostic tests signals ongoing demand for high-value, precision diagnostic platforms, offering prospects for sales of advanced assay kits, consumables, and data analytics tools.

Market Resilience Despite fluctuations in demand due to seasonal and epidemiological factors, Diasorin’s stability and growth trajectory indicate ongoing need for diagnostic supplies and services, especially in diagnostics related to infectious diseases and life sciences applications, providing consistent sales opportunities.

Diasorin Tech Stack

Diasorin uses 8 technology products and services including Microsoft Access, Asana, parallax.js, and more. Explore Diasorin's tech stack below.

  • Microsoft Access
    Database Management Software
  • Asana
    Issue Trackers
  • parallax.js
    Javascript Libraries
  • MuleSoft
    Platform As A Service
  • .NET
    Programming Languages
  • VHDL
    Programming Languages
  • SAP Concur
    Travel And Expense Management
  • Twitter
    Widgets

Media & News

Diasorin's Email Address Formats

Diasorin uses at least 1 format(s):
Diasorin Email FormatsExamplePercentage
First.Last@diasorin.comJohn.Doe@diasorin.com
95%
FirstLast@diasorin.comJohnDoe@diasorin.com
3%
First.MiddleLast@diasorin.comJohn.MichaelDoe@diasorin.com
1%
First@diasorin.comJohn@diasorin.com
1%

Frequently Asked Questions

What is Diasorin's phone number?

Minus sign iconPlus sign icon
You can contact Diasorin's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Diasorin's stock symbol?

Minus sign iconPlus sign icon
Diasorin is a publicly traded company; the company's stock symbol is DSRLF.

What is Diasorin's official website and social media links?

Minus sign iconPlus sign icon
Diasorin's official website is diasorin.com and has social profiles on LinkedIn.

What is Diasorin's SIC code NAICS code?

Minus sign iconPlus sign icon
Diasorin's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Diasorin have currently?

Minus sign iconPlus sign icon
As of December 2025, Diasorin has approximately 2.5K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Ceo & General Manager: A. C.Cfo - Group Supply Chain & Procurement: P. P.Chief Financial Officer And Board Member Diasorin Italia Spa: P. M.. Explore Diasorin's employee directory with LeadIQ.

What industry does Diasorin belong to?

Minus sign iconPlus sign icon
Diasorin operates in the Biotechnology Research industry.

What technology does Diasorin use?

Minus sign iconPlus sign icon
Diasorin's tech stack includes Microsoft AccessAsanaparallax.jsMuleSoft.NETVHDLSAP ConcurTwitter.

What is Diasorin's email format?

Minus sign iconPlus sign icon
Diasorin's email format typically follows the pattern of First.Last@diasorin.com. Find more Diasorin email formats with LeadIQ.

Diasorin

Biotechnology ResearchPiemonte, Italy1001-5000 Employees

Headquartered in Italy and listed on the Italian Stock Exchange within the FTSE MIB Index, Diasorin is a global leader in the In Vitro Diagnostic (IVD) field and, since 2021, has been active in the Life Science business. For over 50 years, the Company has been developing, producing, and marketing reagent kits used by diagnostic laboratories worldwide.
The Group operates across five continents through 35 companies, 4 branches, 10 manufacturing facilities, and 9 research and development centers. Our extensive diagnostic testing and life science offering, continuously enhanced through significant investments in research, positions Diasorin as the player with the broadest range of specialty tests available in the diagnostic market, identifying the Group as “The Diagnostic Specialist.”
With a team of over 3,200 employees worldwide, including more than 400 researchers, we are committed to improving healthcare and enhancing people's quality of life. We value diversity, skills, and talent as key drivers of innovation and excellence, fostering an inclusive work environment that evolves alongside the ever-changing landscape of global healthcare.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DSRLF
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
1001-5000

Section iconFunding & Financials

  • $500M$1B

    Diasorin's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    Diasorin's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.